购物车
- 全部删除
- 您的购物车当前为空
LAS101057 是一种新型可口服且具有有效性和选择性的 A2B receptor 拮抗剂,可用于研究哮喘。
LAS101057 是一种新型可口服且具有有效性和选择性的 A2B receptor 拮抗剂,可用于研究哮喘。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 445 | 6-8周 | |
5 mg | ¥ 1,070 | 5日内发货 | |
10 mg | ¥ 1,650 | 5日内发货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,180 | 5日内发货 |
产品描述 | LAS101057 is a novel orally available and potent and selective A2B receptor antagonist for the study of asthma. |
体内活性 | At 3 mg/kg, LAS101057 is effective in preventing Acetyl-β-methylcholine-induced airway hyperresponsiveness (AHR), and at 10 mg/kg, it inhibits AHR to Acetyl-β-methylcholine to a level virtually equal to that seen with Hexadecadrol at 1 mg/kg[1]. |
分子量 | 335.34 |
分子式 | C18H14FN5O |
CAS No. | 925676-48-8 |
Smiles | Fc1cnccc1-c1ncc(NC(=O)C2CC2)nc1-c1cccnc1 |
密度 | 1.31g/cm3 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (298.20 mM) H2O: < 0.1 mg/mL (insoluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容